Video Experimental Relacionado
Updated: Aug 1, 2026
14:39
Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
Published on: November 5, 2010
Terapia con efedrina en niños asmáticos. Tolerancia clínica y ausencia de efectos secundarios
JAMA
|February 7, 1977
Resumen
Este estudio encontró que la combinación de sulfato de efedrina y teofilina es segura para los niños con asma. La combinación de fármacos no mostró toxicidad ni desarrollo de tolerancia durante ocho semanas, ofreciendo una broncodilatación efectiva.
Área de la Ciencia:
- Pulmonología Pediátrica.
- Farmacología clínica Farmacología clínica.
- Manejo de la Asma Manejo del Asma.
Sus antecedentes:
- El asma es una enfermedad respiratoria crónica que afecta a los niños, a menudo controlada con broncodilatadores.
- La teofilina es un medicamento común para el asma, pero su eficacia y seguridad pueden mejorarse.
- El sulfato de efedrina es un broncodilatador con efectos sinérgicos potenciales cuando se combina con la teofilina.
Objetivo del estudio:
- Evaluar la eficacia y seguridad de un régimen combinado de sulfato de efedrina y teofilina en pacientes pediátricos con asma.
- Para evaluar el desarrollo de tolerancia a esta combinación durante un período de ocho semanas.
- Para determinar la respuesta broncodilatadora y la toxicidad potencial de la combinación de fármacos.
Principales métodos:
- Un estudio doble ciego en el que participaron 16 niños asmáticos de entre 7 y 13 años.
- 13 participantes estuvieron en terapia continua con teofilina.
- Las pruebas de función pulmonar se realizaron cada hora durante seis horas después de la dosis; la toxicidad se monitoreó a través de la observación y el interrogatorio del paciente.
Principales resultados:
- No se informó toxicidad significativa o efectos secundarios adversos por la combinación de sulfato de efedrina y teofilina.
- Los datos de la función pulmonar indicaron una respuesta sostenida al broncodilatador sin una disminución de la eficacia.
- El análisis de los datos de la semana 1 frente a la semana 8 no mostró evidencia de desarrollo de tolerancia.
Conclusiones:
- El sulfato de efedrina puede administrarse con seguridad con dosis terapéuticas de teofilina en pacientes pediátricos con asma.
- La combinación proporciona una broncodilatación efectiva sin inducir tolerancia progresiva o toxicidad.
- Este régimen representa una opción segura y efectiva para el manejo del asma infantil.
Videos de Conceptos Relacionados
01:28Adrenergic Agonists: Mixed-Action Agents
Mixed-action adrenergic agonists, like ephedrine and pseudoephedrine, directly and indirectly affect adrenergic receptors. These agents stimulate adrenoceptors and indirectly release stored neurotransmitters, amplifying the adrenergic response.
Ephedrine and pseudoephedrine lack a catecholamine group, making them less susceptible to degradation by metabolic enzymes. They have increased oral bioavailability and lipophilicity, resulting in a longer duration of action. Their response is reduced by...
Ephedrine and pseudoephedrine lack a catecholamine group, making them less susceptible to degradation by metabolic enzymes. They have increased oral bioavailability and lipophilicity, resulting in a longer duration of action. Their response is reduced by...
01:25Antiasthma Drugs: β2-Adrenoceptor Agonists
Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce relaxation in these...
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce relaxation in these...
01:24Antiasthma Drugs: Methylxanthines
Theophylline, a member of the methylxanthine class of bronchodilators, has long been used in asthma management. While its exact mechanism of action is not fully understood, it is believed to have multiple effects on various cellular processes.
Theophylline is thought to inhibit phosphodiesterase enzymes, increasing intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). This rise in cAMP and cGMP concentrations stimulates cardiac function,...
Theophylline is thought to inhibit phosphodiesterase enzymes, increasing intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). This rise in cAMP and cGMP concentrations stimulates cardiac function,...
01:19Antiasthma Drugs: Leukotriene Modifiers
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
01:30Asthma-IV: Diagnostic and Management
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes: